Trial · NCT04703192
Adverse events272
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 272
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 47 | 133 | 139 |
| other | Anaemia | Blood and lymphatic system disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 11 | 22 | 41 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 35 | 133 | 104 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 4 | 22 | 13 |
| other | Neutropenia | Blood and lymphatic system disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 18 | 133 | 60 |
| other | Neutropenia | Blood and lymphatic system disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 0 | 22 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 38 | 133 | 56 |
| other | Diarrhoea | Gastrointestinal disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 5 | 22 | 5 |
| other | Nausea | Gastrointestinal disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 23 | 133 | 28 |
| other | Nausea | Gastrointestinal disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 4 | 22 | 5 |
| other | Constipation | Gastrointestinal disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 13 | 133 | 13 |
| other | Constipation | Gastrointestinal disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 0 | 22 | 0 |
| other | Vomiting | Gastrointestinal disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 12 | 133 | 13 |
| other | Vomiting | Gastrointestinal disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 3 | 22 | 4 |
| other | Fatigue | General disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 19 | 133 | 28 |
| other | Fatigue | General disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 2 | 22 | 2 |
| other | Pyrexia | General disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 19 | 133 | 27 |
| other | Pyrexia | General disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 3 | 22 | 3 |
| other | Asthenia | General disorders | Cohort 1: Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | 17 | 133 | 22 |
| other | Asthenia | General disorders | Cohort 2: Relapsed/Refractory Adult T-cell Leukemia/Lymphoma | 2 | 22 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04703192/events